Down 40% in 2022, this ASX 200 share is climbing amid insider buying action

a doctor in a white coat sits at her computer with finger on mouth thinking about something in her office with medical equipment in the background.a doctor in a white coat sits at her computer with finger on mouth thinking about something in her office with medical equipment in the background.

The Polynovo Ltd (ASX: PNV) share price is edging higher on Monday morning, up 2.78% to 92.5 cents.

This comes as insiders have recently taken advantage of the share price weakness to purchase more shares.

Despite today’s gains, the medical device company’s shares have fallen 16% in a week, and 40% in 2022.

Directors top up on Polynovo shares

In its most recent statements, Polynovo revealed that a few of its directors each bought a portion of new shares.

Polynovo chair, David Williams picked up 500,000 shares through an on-market acquisition on 5 May at 86.89 cents apiece. He further added to his holding by buying another 1,000,565 shares at 89.94 cents each the following day.

In total, Mr Williams increased his portfolio by roughly 1.5 million Polynovo shares. This means that the chair now has around 20.4 million fully paid ordinary Polynovo shares across all his holdings.

In addition, non-executive director Andrew Lumsden also supplemented his portfolio with 100,000 shares on 5 May. The price paid per share was 87.31 cents.

The Polynovo shares were purchased via an on-market trade, bringing Mr Lumsden’s total to 100,000 shares.

Furthermore, non-executive director Christine Emmanuel conducted a transaction of 115,000 Polynovo shares on 6 May. She ended up getting the best deal in the end, paying 85.51 cents per share.

The above transactions equate to the value of more than $1.52 million.

It appears that the directors believe that Polynovo shares may have bottomed out.

Polynovo share price snapshot

Over the past 12 months, Polynovo shares have plummeted by around 66%.

The company’s share price has been moving along on a downhill trajectory since the start of July 2021.

Based on today’s price, Polynovo commands a market capitalisation of roughly $595.52 million.

The post Down 40% in 2022, this ASX 200 share is climbing amid insider buying action appeared first on The Motley Fool Australia.

Should you invest $1,000 in Polynovo right now?

Before you consider Polynovo, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Polynovo wasn’t one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of January 13th 2022

More reading

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended POLYNOVO FPO. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/RV4XKO0

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s